Apolipoprotein A-i Deficiency
Description
Apolipoprotein AI (Apo A-I) deficiency is a rare lipoprotein metabolism disorder characterized biochemically by complete absence of apolipoprotein AI and extremely low plasma high density lipoprotein (HDL) cholesterol, and clinically by corneal opacities and xanthomas complicated with premature coronary heart disease (CHD).
Clinical Features
Phenotypes and symptoms related to Apolipoprotein A-i Deficiency
- Anemia
- Splenomegaly
- Abnormality of the liver
- Corneal opacity
- Lymphadenopathy
- EMG abnormality
- Hemiplegia/hemiparesis
- Blurred vision
- Xanthomatosis
- Decreased HDL cholesterol concentration
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Apolipoprotein A-i Deficiency Is also known as familial apoa-i deficiency, apoa-i deficiency, familial hypoalphalipoproteinemia.
Researches and researchers
Doctors, researchs, and experts related to Apolipoprotein A-i Deficiency extracted from public data.
Apolipoprotein A-i Deficiency Experts map
Current Researchs and researchers
-
Investigator of research project - Contact person of registry
PARIS — Pr Jean-Philippe GIRARDET
-
Institution/s:
— CHU Paris Est - Hôpital d'Enfants Armand-Trousseau -
Research area/topic::
'Dyslipidemia genetics: phenotype-genotype relationships; vascular consequences in children of hereditary dyslipidemia'
-
Institution/s:
Sources and references
You can check the following sources for additional information.
ORPHANET Rare Disease Symptoms CheckerIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SHASHI-PENA SYNDROME; SHAPNS POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT HEPATIC DISEASE; PKD4 CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J; CMT2J HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5 DUCHENNE MUSCULAR DYSTROPHY SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48 MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50